Perphenazine
Generic Name: perphenazine
Brand Names:
Perphenazine
DESCRIPTION Perphenazine (4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol), a piperazinyl phenothiazine, having the chemical formula, C 21 H 26 CIN 3 OS. It is available as oral tablets containing 2 mg, 4 mg, 8 mg, and 16 mg of perphenazine. Inactive ingredients: microcrystalline cellulose, lactose (monohydrate), hypromellose, sodium starch glycolate, hydroxypropyl cellulose and magnesium stearate.
Overview
DESCRIPTION Perphenazine (4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol), a piperazinyl phenothiazine, having the chemical formula, C 21 H 26 CIN 3 OS. It is available as oral tablets containing 2 mg, 4 mg, 8 mg, and 16 mg of perphenazine. Inactive ingredients: microcrystalline cellulose, lactose (monohydrate), hypromellose, sodium starch glycolate, hydroxypropyl cellulose and magnesium stearate.
Uses
INDICATIONS & USAGE Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation.
Dosage
DOSAGE & ADMINISTRATION Dosage must be individualized and adjusted according to the severity of the condition and the response obtained. As with all potent drugs, the best dose is the lowest dose that will produce the desired clinical effect. Since extrapyramidal symptoms increase in frequency and severity with increased dosage, it is important to employ the lowest effective dose. These symptoms have disappeared upon reduction of dosage, withdrawal of the drug, or administration of an antiparkinsonian agent. Prolonged administration of doses exceeding 24 mg daily should be reserved for hospitalized patients or patients under continued observation for early detection and management of adverse reactions.
Side Effects
ADVERSE REACTIONS Not all of the following adverse reactions have been reported with this specific drug; however, pharmacological similarities among various phenothiazine derivatives require that each be considered. With the piperazine group (of which perphenazine is an example), the extrapyramidal symptoms are more common, and others (e.g., sedative effects, jaundice, and blood dyscrasias) are less frequently seen.
Interactions
Drug Interactions Metabolism of a number of medications, including antipsychotics, antidepressants, β-blockers, and antiarrhythmics, occurs through the cytochrome P450 2D6 isoenzyme (debrisoquine hydroxylase). Approximately 10% of the Caucasian population has reduced activity of this enzyme, so-called “poor” metabolizers. Among other populations the prevalence is not known. Poor metabolizers demonstrate higher plasma concentrations of antipsychotic drugs at usual doses, which may correlate with emergence of side effects.
Warnings
WARNING Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. WARNINGS Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Perphenazine is not approved for the treatment of patients with dementia-related psychosis (see BOXED WARNING). Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements, may develop in patients treated with antipsychotic drugs. Older patients are at increased risk for development of tardive dyskinesia. CONTRAINDICATIONS Perphenazine products are contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine produ...
Storage
HOW SUPPLIED Perphenazine tablets, USP are circular, unscored, film-coated white tablets available as: 16 mg: White to off-white, circular, biconvex, film coated tablets debossed with "I 39" on one side and plain on the other side.
Frequently Asked Questions
What is Perphenazine used for?▼
INDICATIONS & USAGE Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation.
What are the side effects of Perphenazine?▼
ADVERSE REACTIONS Not all of the following adverse reactions have been reported with this specific drug; however, pharmacological similarities among various phenothiazine derivatives require that each be considered. With the piperazine group (of which perphenazine is an example), the extrapyramidal symptoms are more common, and others (e.g., sedative effects, jaundice, and blood dyscrasias) are less frequently seen.
What are the important warnings for Perphenazine?▼
WARNING Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. WARNINGS Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Perphenazine is not approved for the treatment of patients with dementia-related psychosis (see BOXED WARNING). Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements, may develop in patients treated with antipsychotic drugs. Older patients are at increased risk for development of tardive dyskinesia. CONTRAINDICATIONS Perphenazine products are contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine produ...
Related Medications
Adenosinum Triphosphoricum Dinatrum, Nadidum, Argentum Nitricum, Ipecacuanha, Robinia Pseudoacacia, Sulphur, Origanum Vulgare, Duodenum (suis), Esophagus (suis), Funiculus Umbilicalis Suis, Stomach (suis), Nux Vomica, Coumarinum, Erythraea Centaurium, Pancreatinum, Muriaticum Acidum, Citricum Acidum, Formicum Acidum, Sarcolacticum Acidum, Coenzyme A, Proteus (morgani)
adenosinum triphosphoricum dinatrum, nadidum, argentum nitricum, ipecacuanha, robinia pseudoacacia, sulphur, origanum vulgare, duodenum (suis), esophagus (suis), funiculus umbilicalis suis, stomach (suis), nux vomica, coumarinum, erythraea centaurium, pancreatinum, muriaticum acidum, citricum acidum, formicum acidum, sarcolacticum acidum, coenzyme a, proteus (morgani)
Calculi Dissolution Agent [EPC]
HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to heartburn and esophageal reflux.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Euphrasia Officianalis, Hoitzia, Mercurius Corrosivus, Ruta Graveolens, Sulphur
euphrasia officianalis, hoitzia, mercurius corrosivus, ruta graveolens, sulphur
Purpose Euphrasia officianalis - Itchiness, grittiness Hoitzia - Dryness, redness Mercurius corrosivus HPUS 15X - Burning, swelling Ruta graveolens - Tired eyes, eye strain Sulphur HPUS - Redness, dryness
Advanced Care Apple And White Tea 72h Antiperspirant Deodorant
advanced care apple and white tea 72h antiperspirant deodorant
Purpose antiperspirant
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.